Dermatology · General Practice · 2 h ago
Article highlights Epimax-associated ocular surface toxicity in primary care
A British Journal of General Practice article draws attention to Epimax-related ocular surface toxicity (EROST), described as an avoidable cause of ocular morbidity associated with emollient use. The supplied text reports prior findings and safety warnings but provides no study design, patient numbers, or detailed clinical management guidance.
- Article describes ocular toxicity associated with Epimax use.
- Cases reportedly continue to reach ophthalmology services.
- Supplied text provides no case numbers or management details.
Atopic eczema is common in UK primary care, and emollients are a mainstay of its management. The article focuses on Epimax, a commonly used emollient containing liquid paraffin, yellow soft paraffin, and cetomacrogol emulsifying wax, and discusses ocular surface toxicity associated with its use, termed Epimax-related ocular surface toxicity (EROST).
The authors cite findings from Glasgow and reports from other centres identifying Epimax as a cause of ocular surface toxicity. They state that cases continue to reach ophthalmology services despite growing awareness and regulatory safety warnings. The supplied text gives no study design, case numbers, incidence estimates, or details of the warnings, diagnosis, treatment, or prevention measures.
The article aims to raise awareness among GPs, pharmacists, and other primary care clinicians, noting that patients may assume the emollient is suitable for any skin area unless told otherwise. The full article was not accessible in the supplied material, so its specific clinical recommendations and supporting evidence cannot be assessed here.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
British Journal of General Practice: Epimax ® -related ocular surface toxicity (EROST): an iatrogenic condition for the attention of primary care clinicians ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.
